Refine by
Therapy Development Articles & Analysis
171 articles found
Lipid nanoparticles (LNPs) occupy a central role in the development of innovative nucleic acid–based therapies. Used as vectors to deliver therapeutic molecules into cells, LNPs are a critical driver across vaccination, oncology, and gene therapy. Their development remains technically demanding and resource-intensive.Drawing on ...
Single cell isolation is essential for reproducibility and regulatory compliance in modern life science workflows, including stable cell line development, gene editing, and single-cell omics. Precise isolation of individual cells enables the capture of functional heterogeneity and supports data-driven decisions in research, development, and manufacturing ...
ByCytena
Challenges in Enzyme-Based Rare Disease Therapies Although therapeutic enzymes have demonstrated clear clinical benefits, several challenges remain in the development and application of enzyme-based treatments. ...
Disease Mechanism and Biomarker Discovery l Explore the molecular mechanisms of disease development, including cancer, neurological diseases, metabolic diseases and so on. l Discover disease-related gene expression patterns and biomarkers for diagnosis, prognosis and treatment monitoring. Analysis of Cell Types and States l Reveal heterogeneity and functional differences ...
They serve as essential signaling molecules that not only support the development of the nervous system during embryonic stages but also maintain neuronal health throughout an individual’s life. ...
In the realm of medicine, it holds promise for the development of targeted therapies for genetic disorders. By pinpointing and correcting specific mutations, researchers can pave the way for innovative treatment options that were previously thought to be unattainable. ...
The rat thymus, an essential organ in the immune system, plays a crucial role in the development and maturation of T-cells. Investigating the thymus of rats provides valuable insights into immunological processes and disease mechanisms. ...
This molecular insight is crucial for understanding the pathophysiological processes underlying kidney diseases and for the development of targeted therapies. Benefits of Using BALB/C Mouse Kidney FFPE Blocks Utilizing BALB/C mouse kidney FFPE blocks presents several advantages. ...
In biotechnology and agriculture, analyzing sterols can help in developing new drugs or engineering more resilient crops. Therefore, a robust Sterol Lipids Analysis service is an indispensable tool for researchers, clinicians, and drug developers. ...
The mature ELANE enzyme is synthesized as a zymogen during neutrophil development and undergoes proteolytic activation and granule packaging within promyelocytes in the bone marrow. ...
Adenoviruses are a group of viruses that have gained significant attention in recent years, particularly in the fields of gene therapy, vaccine development, and cancer treatment. With their ability to deliver genetic material into cells effectively, adenoviruses serve as valuable vectors in various biomedical applications. ...
Targeting specific kinases has become a promising strategy for developing more effective and selective cancer therapies. Kinase screening services assist researchers in identifying active inhibitors, understanding kinase biology, and providing insights into the mechanisms of action of drug candidates. ...
In cancer research, these vectors allow for the investigation of gene function and the potential development of gene therapies targeting tumor cells. In regenerative medicine, they have the capability to correct genetic disorders by delivering therapeutic genes to affected tissues. Moreover, in model organism studies, CRISPR/Cas9 lentiviral systems are employed ...
These chemokines protein allows researchers to study the functional dynamics of chemokine-receptor interactions in controlled environments, facilitating the development of targeted therapies for a range of diseases, including cancer, autoimmune disorders, and chronic inflammatory conditions. ...
Alfa Cytology uses the latest biotechnological platforms to improve the development efficiency of one-stop solutions targeting FAP. Through the synergy of recombinant DNA technology and high-throughput screening researchers develop therapies specifically designed to match the distinctive traits of tumors expressing FAP. Alfa Cytology ...
Cancer treatment has witnessed transformative advancements over the past few decades, notably with the emergence of CAR-T (Chimeric Antigen Receptor T-cell) therapy. This revolutionary therapy harnesses the body's immune system by genetically engineering T-cells to target and destroy cancer cells. ...
M-FISH helps in identifying specific genetic alterations associated with different cancer types, thereby aiding in targeted therapy development. Genetic Disorders: The technique is valuable in diagnosing genetic disorders caused by chromosomal abnormalities. ...
In recent years, the fight against cancer has seen significant advances, particularly with the emergence of targeted therapy. Among the most promising strategies in this domain is the development of radioactive drug conjugates(RDCs). ...
Furthermore, Alfa Cytology demonstrates its dedication to converting scientific discoveries into innovative solutions through its extensive development services on therapeutic antibody for cancer therapy. The firm develops monoclonal antibodies that target tumor-specific antigens through the services. ...
Their versatility, stability, and specificity position them as a promising alternative to traditional antibody formats, paving the way for future developments in antibody-based therapies. ...